Search results
Dow Jones Rises Amid Fed Speeches; AI Stock Palo Alto Dives On Earnings
Investor's Business Daily· 5 days agoMicrosoft and Trade Desk are featured in this Stocks Near A Buy Zone column. An essential resource...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 3 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Billionaire Ken Griffin Is Buying These Dividend Stocks Hand Over Fist. Should You? | The Motley...
The Motley Fool· 2 days agoThe billionaire hedge fund manager doesn't need dividend income. But he'll get more of it after his...
Ignorance isn't bliss
Santa Maria Sun· 7 days agoJohn Donegan is fortunate that, as far as I know, there are no state laws that make it a crime to be ignorant. After all, it’s been almost 50 years since the American Psychiatric Association stopped calling homosexuality a mental illness.
Prostate Cancer Screening: What Does Your Patient Fear Most?
Medscape· 4 days agoDr Neil Skolnik distills available recommendations (including recent AUA guidance) to help...
Why Top 4% Biotech Stock, Merus, Just Catapulted To A Record High
Investor's Business Daily· 1 day agoMerus stock catapulted to a record high Friday after its experimental regimen for head-and-neck...
Why This Top 4% Biotech Just Catapulted To A Record High
Investor's Business Daily· 1 day agoThe Netherlands-based biotech paired its drug, petosemtamab, with Merck's (MRK) cancer blockbuster,...
Healthcare data company Atropos Health receives $33m in Series B funding round
Hospital Management via Yahoo Finance· 2 days agoThe funding round involved participation from both new and existing investors, including McKesson...
Dow Jones Futures Rise: AI Stock Palo Alto Plunges; Nvidia Earnings, Fed Minutes Loom
Investor's Business Daily· 5 days agoAnd Dow Jones tech icons Apple and Microsoft ended higher in today's stock market, with Apple and...
How Trump's presidency became a roller-coaster ride for many of America's top CEOs
Business Insider· 4 days agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
